Search research articles
Contact Us
Filters
Showing results (51-60 of 554) with videos related to
Page
of 56
Sort By:
Schizophrenia Research
|
February 10, 2017
GABA and schizophrenia: Where we stand and where we need to go
Jill R Glausier, David A Lewis
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 23, 2012
Stroke risk in maintenance hemodialysis
William G Herrington, David A Lewis
Expert Review of Anti-Infective Therapy
|
May 28, 2005
Treatment of chancroid in resource-poor countries
Naa Torshie Annan, David A Lewis
Schizophrenia Bulletin
|
February 23, 2012
NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia
Guillermo Gonzalez-Burgos, David A Lewis
The American Journal of Medicine
|
October 4, 2011
Contraindications to pharmacologic therapies for gout
David A Lewis, William G Herrington
Cerebral Cortex (New York, N.Y. : 1991)
|
February 10, 2006
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis
Stephen M Eggan, David A Lewis
The Journal of Comparative Neurology
|
April 7, 2004
Cortical connections of the lateral mediodorsal thalamus in cynomolgus monkeys
Susan L Erickson, David A Lewis
Sexually Transmitted Diseases
|
August 8, 2008
The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis
Leigh F Johnson, David A Lewis
The Journal of Clinical Investigation
|
April 3, 2009
Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies
David A Lewis, Robert A Sweet
Schizophrenia Bulletin
|
July 24, 2014
Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia
David W Volk, David A Lewis
Page
of 56
Search research articles
Search
Showing results (51-60 of 554) with videos related to
Sort By:
Page
of 56
Schizophrenia Research
|
February 10, 2017
GABA and schizophrenia: Where we stand and where we need to go
Jill R Glausier, David A Lewis
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 23, 2012
Stroke risk in maintenance hemodialysis
William G Herrington, David A Lewis
Expert Review of Anti-Infective Therapy
|
May 28, 2005
Treatment of chancroid in resource-poor countries
Naa Torshie Annan, David A Lewis
Schizophrenia Bulletin
|
February 23, 2012
NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia
Guillermo Gonzalez-Burgos, David A Lewis
The American Journal of Medicine
|
October 4, 2011
Contraindications to pharmacologic therapies for gout
David A Lewis, William G Herrington
Cerebral Cortex (New York, N.Y. : 1991)
|
February 10, 2006
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis
Stephen M Eggan, David A Lewis
The Journal of Comparative Neurology
|
April 7, 2004
Cortical connections of the lateral mediodorsal thalamus in cynomolgus monkeys
Susan L Erickson, David A Lewis
Sexually Transmitted Diseases
|
August 8, 2008
The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis
Leigh F Johnson, David A Lewis
The Journal of Clinical Investigation
|
April 3, 2009
Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies
David A Lewis, Robert A Sweet
Schizophrenia Bulletin
|
July 24, 2014
Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia
David W Volk, David A Lewis
Page
of 56